Heron Therapeutics (HRTX) Interest & Investment Income (2016)
Historic Interest & Investment Income for Heron Therapeutics (HRTX) over the last 5 years, with Q4 2016 value amounting to $1.1 million.
- Heron Therapeutics' Interest & Investment Income changed N/A to $1.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $445000.0, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 552.91% up from last year.
- Heron Therapeutics' Interest & Investment Income amounted to $1.1 million in Q4 2016.
- Heron Therapeutics' Interest & Investment Income's 5-year high stood at $1.1 million during Q4 2016, with a 5-year trough of -$209000.0 in Q3 2013.
- Moreover, its 3-year median value for Interest & Investment Income was -$196000.0 (2012), whereas its average is -$19250.0.
- Examining YoY changes over the last 5 years, Heron Therapeutics' Interest & Investment Income showed a top increase of 4448.67% in 2012 and a maximum decrease of 600000.0% in 2012.
- Quarter analysis of 3 years shows Heron Therapeutics' Interest & Investment Income stood at -$197000.0 in 2012, then fell by 6.09% to -$209000.0 in 2013, then skyrocketed by 606.7% to $1.1 million in 2016.
- Its Interest & Investment Income stands at $1.1 million for Q4 2016, versus -$209000.0 for Q3 2013 and -$204000.0 for Q2 2013.